Index of artpub/2024/309339/

Brasó-Maristany, Fara
Patritumab deruxtecan in HER2-negative breast cancer : part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response
2024
https://ddd.uab.cat/record/309339